Sgltr Tablet is an anti-diabetic medication that is primarily used to treat type 2 diabetes mellitus and non-alcoholic steatohepatitis (non-alcoholic fatty liver disease). Diabetes mellitus is a metabolic disorder characterized by elevated blood sugar levels. It happens when insulin (a hormone produced by the pancreatic's beta cells) is resistant to breaking down glucose to create energy (insulin resistance) or when the pancreas (an organ beneath the stomach) produces little or no insulin at all. Sgltr Tablet is not recommended for those with type 1 diabetes.

Usage instructions-

• The dose and duration of Sgltr Tablet should be taken as directed by your doctor. You can have Sgltr Tablet with meals or without.

How it works-

Sgltr Tablet includes the diabetes medication Remogliflozin etabonate. It decreases blood sugar levels in type 2 diabetes mellitus by removing excess sugars through urine and thereby aids in diabetic glycemic management.

Safety information-

Pregnancy

Sgltr Tablet is probably not safe to use in pregnancy. There are limited human studies, but animal studies have shown adverse effects on the developing baby. Consult your doctor.

Breastfeeding

It is probably not safe to breastfeed while taking Sgltr Tablet. There is limited human data suggesting that the drug may enter breast milk and cause harm to the baby.

Alcohol

It is unsafe to take alcohol with Sgltr Tablet.

Driving

If you have too high or too low blood sugar, it could affect your ability to drive. If you experience these symptoms, don't drive.

Kidney

Sgltr Tablet should be avoided in those who have kidney problems. Please consult your physician.

Liver

Sgltr Tablet should be avoided in those who have liver problems. Please consult your physician.